These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1975956)

  • 1. Evaluation of the pharmacological similarities between phenylpropanolamine and amphetamine: effects on schedule-controlled behavior.
    Wagner GC; Jarvis MF
    Synapse; 1990; 6(1):101-5. PubMed ID: 1975956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation.
    Brocco MJ; McMillan DE
    J Pharmacol Exp Ther; 1983 Jan; 224(1):34-9. PubMed ID: 6848748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioral and neurochemical evaluation of phenylpropanolamine.
    Woolverton WL; Johanson CE; de la Garza R; Ellis S; Seiden LS; Schuster CR
    J Pharmacol Exp Ther; 1986 Jun; 237(3):926-30. PubMed ID: 3712285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interresponse time changes as a function of water deprivation and amphetamine.
    Brown BM; Seiden LS
    J Pharmacol Exp Ther; 1975 May; 193(2):701-12. PubMed ID: 1142113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of central catecholamine and hypothalamic neuropeptide Y genome in the development of tolerance to phenylpropanolamine-mediated appetite suppression.
    Hsieh YS; Yang SF; Chiou HL; Kuo DY
    Behav Neurosci; 2007 Oct; 121(5):933-40. PubMed ID: 17907825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacology of the anorexic effect of phenylpropanolamine.
    Wellman PJ
    Drugs Exp Clin Res; 1990; 16(9):487-95. PubMed ID: 2100250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An examination of d-amphetamine self-administration in pedunculopontine tegmental nucleus-lesioned rats.
    Alderson HL; Latimer MP; Blaha CD; Phillips AG; Winn P
    Neuroscience; 2004; 125(2):349-58. PubMed ID: 15062978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phencyclidine on schedule-controlled responding following neurotoxic lesions of the striatum.
    Carlson KM; Wagner GC
    Life Sci; 2005 Jun; 77(4):372-85. PubMed ID: 15894007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Similarities between the stimulus properties of phenylpropanolamine and amphetamine.
    Lee F; Stafford I; Hoebel BG
    Psychopharmacology (Berl); 1989; 97(3):410-2. PubMed ID: 2497491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules.
    Green TA; Gehrke BJ; Bardo MT
    Psychopharmacology (Berl); 2002 Aug; 162(4):373-8. PubMed ID: 12172690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of drugs on schedule-controlled behavior in rats during chronic haloperidol administration.
    Rastogi SK; McMillan DE
    J Pharmacol Exp Ther; 1985 Feb; 232(2):295-300. PubMed ID: 3968634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-administration of phenylpropanolamine (PPA) by rats previously trained to self-administer amphetamine.
    Wellman PJ; Shelton K; Schenk S
    Pharmacol Biochem Behav; 1989 Sep; 34(1):187-91. PubMed ID: 2626448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
    Martin-Iverson MT; Yamada N; By AW; Lodge BA
    J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to novel environmental stimuli decreases amphetamine self-administration in rats.
    Klebaur JE; Phillips SB; Kelly TH; Bardo MT
    Exp Clin Psychopharmacol; 2001 Nov; 9(4):372-9. PubMed ID: 11764013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of d-amphetamine on responding of squirrel monkeys maintained under second-order schedules of food presentation, electric shock presentation or stimulus-shock termination.
    Barrett JE; Katz JL; Glowa JR
    J Pharmacol Exp Ther; 1981 Sep; 218(3):692-700. PubMed ID: 7264953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenylpropanolamine and amphetamine disrupt postprandial satiety in rats.
    Rosofsky M; Geary N
    Pharmacol Biochem Behav; 1989 Dec; 34(4):797-803. PubMed ID: 2623033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of amphetamine on differential reinforcement of low rates of responding.
    Saulsgiver KA; McClure EA; Wynne CD
    Behav Pharmacol; 2007 Mar; 18(2):119-33. PubMed ID: 17351419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catecholamines and drug-behavior interactions.
    Seiden LS; MacPhail RC; Oglesby MW
    Fed Proc; 1975 Aug; 34(9):1823-31. PubMed ID: 1097267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.